(Reuters) – Biotech company Moderna Inc could earn tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If you lose, the value of the early stage business could collapse. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which …
Read More »
Text size Joseph Prezioso / Getty Images Shares of Modern biotechnology fell 6.2% on Thursday afternoon after health news website Stat reported that the company was delaying the start of a Phase 3 trial of its experimental Covid-19 vaccine. The report, based on quotes from unidentified sources described as “investigators,” …
Read More »
GENEVA / LONDON (Reuters) – The World Health Organization (WHO) should soon obtain results of clinical trials it is carrying out on drugs that could be effective in treating patients with COVID-19, its Director said on Friday. General, Tedros Adhanom Ghebreyesus. The Director General of the World Health Organization (WHO), …
Read More »
(Reuters) – Biotech company Moderna Inc could earn tens of billions of dollars in sales and stock appreciation if it wins the race for a COVID-19 vaccine. If you lose, the value of the early stage business could collapse. FILE PHOTO: A sign marks the headquarters of Moderna Inc, which …
Read More »
Text size Daniel Acker / Bloomberg Shares of the large pharmaceutical company Pfizer continue to rise one day after the company revealed promising and detailed data on a trial of its experimental vaccine Covid-19. Analysts said the highly aggressive timeline the company outlined on Wednesday was exciting, but far from …
Read More »